Evidence map›Paper›PMID 29200184›Full record

ArticleThe Pediatric infectious disease journal2018

Structural Neuroimaging and Neuropsychologic Signatures in Children With Vertically Acquired HIV.

Robert Paul, Wasana Prasitsuebsai, Neda Jahanshad, Thanyawee Puthanakit, Paul Thompson, Linda Aurpibul, Rawiwan Hansudewechakul, Pope Kosalaraksa, Suparat Kanjanavanit, Chaiwat Ngampiyaskul and 10 more

Open access · greenAbstract read
In one paragraph

Article in The Pediatric infectious disease journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 12 institutions in 4 countries.

Robert PaulFrom the Missouri Institute of Mental Health, University of Missouri, St. Louis, Missouri.
Wasana PrasitsuebsaiHIV Netherlands Australia Thailand (HIV-NAT) Research Collaboration, Thai Red Cross AIDS Research Center, Bangkok, Thailand.
Neda JahanshadImaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of the University of Southern California, Marina del Rey, California.
Thanyawee PuthanakitHIV Netherlands Australia Thailand (HIV-NAT) Research Collaboration, Thai Red Cross AIDS Research Center, Bangkok, Thailand.
Paul ThompsonImaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of the University of Southern California, Marina del Rey, California.
Linda AurpibulResearch Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
Rawiwan HansudewechakulChiangrai Prachanukroh Hospital, Chiang Rai, Thailand.
Pope KosalaraksaSrinagarind Hospital, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Suparat KanjanavanitNakornping Hospital, Chiang Mai, Thailand.
Chaiwat NgampiyaskulPrapokklao Hospital, Chantaburi, Thailand.
Wicharn LuesomboonQueen Savang Vadhana Memorial Hospital, Chongburi, Thailand.
Sukalaya LerdlumDepartment of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Mantana PothisriDepartment of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Pannee VisrutaratnaDepartment of Radiology, Chiang Mai University, Chiang Mai, Thailand.
Victor ValcourMemory and Aging Center, Department of Neurology, University of California, San Francisco, California.
Talia M NirImaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of the University of Southern California, Marina del Rey, California.
Arvin SaremiImaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of the University of Southern California, Marina del Rey, California.
Stephen KerrHIV Netherlands Australia Thailand (HIV-NAT) Research Collaboration, Thai Red Cross AIDS Research Center, Bangkok, Thailand.
Jintanat AnanworanichHIV Netherlands Australia Thailand (HIV-NAT) Research Collaboration, Thai Red Cross AIDS Research Center, Bangkok, Thailand.
Pediatric Randomized Early versus Deferred Initiation in Cambodia and Thailand (PREDICT) Study Group
University of Southern California · USChulalongkorn University · THChiang Mai University · THHIV Netherlands Australia Thailand Research Collaboration · THChiangRai Prachanukroh Hospital · THHenry M. Jackson Foundation · USKhon Kaen University · THMissouri Institute of Mental Health · USNakornping Hospital · THPrapokklao Hospital · THQueen Saovabha Memorial Institute · THUniversity of California, San Francisco · US

Funding

Treatment of HIV/Tuberculosis Co-DiseaseU19AI053741 · NIAID · HIV-NAT, THE THAI RED CROSS AIDS RCH CTR · PI RUXRUNGTHAM, KIAT · 2004 to 2010
$6.3M
Neurodevelopment and Imaging among HIV-infected Children from the PREDICT studyR01MH089722 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VALCOUR, VICTOR · 2010 to 2014
$3.1M
Determinants of Resilience in Youth with HIV infection and Youth affected by HIVR01MH102151 · NIMH · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI ROBB, MERLIN L · 2014 to 2018
$2.3M
NIAID NIH HHS U19 AI053741NIMH NIH HHS R01 MH089722NIMH NIH HHS R01 MH102151
6 · The paper itself

Abstract

backgroundChildren with vertically acquired HIV exhibit persistent cognitive impairments, yet the corresponding neuroimaging signature of vertical infection remains unclear.

methodsFifty healthy control children and 51 vertically infected children were included in the study. The HIV-infected group consisted of survivors who had not received antiretroviral therapy at birth. The HIV-infected group averaged 11.4 (2.5) years of age, with a median CD4 count of 683 cells/mm(3). Most (71%) of the HIV-infected children were on antiretroviral therapy for a median of 34 months (range: 33-42) with HIV RNA <40 copies/mL in 89% of the sample. The HIV-uninfected group averaged 10.6 (2.6) years of age. Magnetic resonance imaging was acquired to determine volumes of the caudate, putamen, thalamus, pallidum, hippocampus, nucleus accumbens, total white matter, total gray matter and cortical gray matter. Correlational analyses examined the degree of shared variance between brain volumes and both cognitive performances and laboratory markers of disease activity (T cells and plasma viral load).

resultsHIV-infected children exhibited larger volumes of the caudate, nucleus accumbens, total gray matter and cortical gray matter when compared with the controls. Volumetric differences were predominately evident in children under 12 years of age. HIV-infected children performed worse than controls on most neuropsychologic tests, though neither cognitive performances nor laboratory markers corresponded to brain volumes in the HIV-infected children.

conclusionsOutcomes of the present study suggest abnormal brain maturation among HIV-infected pediatric survivors. Longitudinal studies of brain integrity and related resilience factors are needed to determine the impact of neuroimaging abnormalities on psychosocial function in pediatric HIV.

Indexed as

Infectious Disease Transmission, VerticalNeuroimagingNeuropsychological TestsAdolescentBrainChildCognitive DysfunctionFemaleHIVHIV InfectionsHumansLongitudinal StudiesMagnetic Resonance ImagingMaleViral Load

Identifiers

PMID29200184
PMCPMC5984109
OpenAlexW2771450715

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.